<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03544541</url>
  </required_header>
  <id_info>
    <org_study_id>Cardio-Risk-T1D-SI</org_study_id>
    <nct_id>NCT03544541</nct_id>
  </id_info>
  <brief_title>Cardiometabolic Risk in Children With Type 1 Diabetes.</brief_title>
  <official_title>Association Between Metabolic Control and Cardiometabolic Risk in Children With Type 1 Diabetes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ljubljana, Faculty of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ljubljana, Faculty of Medicine</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To access the relationship between metabolic control of children and adolescents with type 1
      diabetes and cardiometabolic risk through noninvasive imaging modalities to assess the early
      vasculature changes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 5, 2018</start_date>
  <completion_date type="Actual">November 30, 2019</completion_date>
  <primary_completion_date type="Actual">November 30, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Carotid Intima-Media Thickness</measure>
    <time_frame>24 months</time_frame>
    <description>Non-invasive (Doppler Ultrasound) measurement of Carotid Intima-Media Thickness</description>
  </primary_outcome>
  <enrollment type="Actual">150</enrollment>
  <condition>Type1 Diabetes Mellitus</condition>
  <condition>Metabolic Complication</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Nationwide cohort of children and adolescents with type 1 diabetes
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 diabetes for more than 0.5 year

          -  Age â‰¥ 10 years up to 25 years (inclusive)

          -  The subject/carer is willing to follow study specific instructions

        Exclusion Criteria:

          -  Youth with maturity-onset diabetes of the young, hybrid, other, or missing type

          -  Any significant diseases / conditions including psychiatric disorders and substance
             abuse that in the opinion of the investigator is likely to affect the subject's
             ability to complete the study

          -  Current use of the following medications: medications that are used to lower blood
             glucose such as Pramlintide, Metformin and GLP-1 analogs. Beta blockers,
             glucocorticoids and other medications, which in the judgment of the investigator would
             be a contraindication to participation in the study (Anticoagulant therapy e.g.
             Plavix, LMW heparin, Coumadin, Immunosuppressant therapy)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>UMC-University Children's Hospital</name>
      <address>
        <city>Ljubljana</city>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>February 27, 2018</study_first_submitted>
  <study_first_submitted_qc>May 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2018</study_first_posted>
  <last_update_submitted>January 31, 2020</last_update_submitted>
  <last_update_submitted_qc>January 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

